Amyotrophic lateral sclerosis: applications of stem cells – an update
Open Access
- 1 October 2010
- journal article
- review article
- Published by Taylor & Francis in Stem Cells and Cloning: Advances and Applications
- Vol. ume 3, 145-156
Abstract
Neurodegenerative diseases are a growing public health challenge, and amyotrophic lateral sclerosis (ALS) remains a fatal incurable disease. The advent of stem cell therapy has opened new horizons for both researchers and ALS patients, desperately looking for a treatment. ALS must be considered a systemic disease affecting many cell phenotypes besides motor neurons, even outside the central nervous system. Cell replacement therapy needs to address the specific neurobiological issues of ALS to safely and efficiently reach clinical settings. Moreover, the enormous potential of induced pluripotent cells directly derived from patients for modeling and understanding the pathological mechanisms, in correlation with the discoveries of new genes and animal models, provides new opportunities that need to be integrated with previously described transplantation strategies. Finally, a careful evaluation of preclinical data in conjunction with wary patient choice in clinical trials needs to be established in order to generate meaningful results.Keywords
This publication has 141 references indexed in Scilit:
- Rethinking ALS: The FUS about TDP-43Cell, 2009
- Human neural stem cell grafts in the spinal cord of SOD1 transgenic rats: Differentiation and structural integration into the segmental motor circuitryJournal of Comparative Neurology, 2009
- Induced pluripotent stem cells from a spinal muscular atrophy patientNature, 2008
- Focal transplantation–based astrocyte replacement is neuroprotective in a model of motor neuron diseaseNature Neuroscience, 2008
- Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosisNature Neuroscience, 2008
- Functional recovery in rats with ischemic paraplegia after spinal grafting of human spinal stem cellsNeuroscience, 2007
- Non–cell autonomous effect of glia on motor neurons in an embryonic stem cell–based ALS modelNature Neuroscience, 2007
- Mice deficient in the ALS2 gene exhibit lymphopenia and abnormal hematopietic functionJournal of Neuroimmunology, 2007
- Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosisProceedings of the National Academy of Sciences, 2006
- Directed Differentiation of Embryonic Stem Cells into Motor NeuronsCell, 2002